In conversation with...
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke 8:45 Beau Ances on amyloid biomarkers in Alzheimer’s 11:34 Axel Petzold on the diagnosis and classification of optic neuritis 20:03 Maeike Zijlmans on using biomarkers to tailor epilepsy surgery 14:37 Jerome Siegel on sleep habits 43:50 Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy 17:13 Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy 22:58 Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies 18:52 Mark Hallett on functional neurological disorder 8:43 Eva Feldman on advances in understanding ALS 22:43 Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's 27:15 John Collinge on a treatment for CJD 14:45 Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2 7:55 Giuseppe Citerio on frailty and TBI 9:35 Alberto Costa on memantine in adolescents and young adults with Down syndrome 15:14 Olivier Rascol on amantadine for patients with movement disorders 28:27 Antonio Uccelli on stems cells for MS 18:08 Priya Palta on blood pressure control and cognitive decline 16:47 Adam Boxer on tau biomarkers 12:13 Irene Cortese on the difficulties of designing clinical trials 9:58 Doug Turnbull on mitochondrial diseases in adults 20:12 Geert Jan Biessels on predicting post-stroke cognitive impairment 7:59 Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS 8:36 Anne MacGregor on menstrual migraine 12:50 Peter Rothwell on asymptomatic carotid stenosis and stroke 9:25